Prevalence of Anemia and Its Relation with Shwachman Score in Children with Cystic Fibrosis

Overview

Journal Tanaffos

Specialty Pulmonary Medicine

Date 2023 Nov 3

PMID 37920324

Authors

Mona Afifi

Maryam Hassanzad

Fatemeh Malek

Sharareh Kamfar

Mihan Pourabdollah

Poopak Farnia

Nooshin Baghaei

Ali Valinejadi

Ali Akbar Velayati

Affiliations

Soon will be listed here.

Abstract

Background: Cystic fibrosis is a chronic and progressive genetic disease with a worldwide prevalence. As the disease progresses, symptoms develop, and make its management more challenging. Accumulating evidence suggests that early diagnosis of CF can significantly contribute to preventing reported nutritional problems including anemia, vitamin deficiencies, and hypoalbuminemia. This cross-sectional study was conducted to assess disease severity in cystic fibrosis patients using the Shwachman-Kulczycki score, as well as to determine its relation with anemia and vitamin D deficiency.

Materials And Methods: Clinical and CF-related laboratory data were collected from the medical records of 57 CF patients with a definitive diagnosis. At the time of diagnosis, physicians performed simultaneous, blood sampling and scoring of patients using the Shwachman scoring system.

Results: The mean age of patients was 16.12±6.48 years. Total scores of 86-100, 71-85, 56-70, 41-55, and <40, were reported in 5.4%, 7.1%, 14.3%, 14.3%, and 58.9% of CF patients, respectively. A significant correlation was found between disease severity and patients' age (P=0.02). The analysis also showed that the disease severity was significantly higher in anemic patients when compared to non-anemics (p =0.006). Based on the results, 33 patients with normochromic, 11 patients with microcytic, and 6 patients with macrocytic anemia were diagnosed in this study. We did not find a significant difference between disease severity and vitamin D levels (P=0.150).

Conclusion: The scoring system used in the current study could reflect properly the clinical status of CF patients. However, simultaneous use of various methods using a larger sample size for comparison of results is suggested to improve the accuracy of findings.

References

Ater J, Herbst J, LANDAW S, OBrien R . Relative anemia and iron deficiency in cystic fibrosis. Pediatrics. 1983; 71(5):810-4. View

De Boer K, Vandemheen K, Tullis E, Doucette S, Fergusson D, Freitag A . Exacerbation frequency and clinical outcomes in adult patients with cystic fibrosis. Thorax. 2011; 66(8):680-5. DOI: 10.1136/thx.2011.161117. View

Rovner A, Stallings V, Schall J, Leonard M, Zemel B . Vitamin D insufficiency in children, adolescents, and young adults with cystic fibrosis despite routine oral supplementation. Am J Clin Nutr. 2007; 86(6):1694-9. DOI: 10.1093/ajcn/86.5.1694. View

Lehoux Dubois C, Labreche E, Boudreau V, Colomba J, Mailhot M, Lavoie A . Extra-skeletal impact of vitamin D supplementation protocol in an adult population with cystic fibrosis. Clin Nutr. 2018; 38(4):1666-1671. DOI: 10.1016/j.clnu.2018.08.013. View

Vandenbranden S, McMullen A, Schechter M, Pasta D, Michaelis R, Konstan M . Lung function decline from adolescence to young adulthood in cystic fibrosis. Pediatr Pulmonol. 2012; 47(2):135-43. PMC: 4219484. DOI: 10.1002/ppul.21526. View

Rosenstein B, Cutting G . The diagnosis of cystic fibrosis: a consensus statement. Cystic Fibrosis Foundation Consensus Panel. J Pediatr. 1998; 132(4):589-95. DOI: 10.1016/s0022-3476(98)70344-0. View

Wani W, Nazir M, Bhat J, Malik E, Ahmad Q, Charoo B . Vitamin D status correlates with the markers of cystic fibrosis-related pulmonary disease. Pediatr Neonatol. 2018; 60(2):210-215. DOI: 10.1016/j.pedneo.2018.07.001. View

Davis P . Cystic fibrosis since 1938. Am J Respir Crit Care Med. 2005; 173(5):475-82. DOI: 10.1164/rccm.200505-840OE. View

Grey V, Atkinson S, Drury D, Casey L, Ferland G, Gundberg C . Prevalence of low bone mass and deficiencies of vitamins D and K in pediatric patients with cystic fibrosis from 3 Canadian centers. Pediatrics. 2008; 122(5):1014-20. DOI: 10.1542/peds.2007-2336. View

10.

Farrell P, Rosenstein B, White T, Accurso F, Castellani C, Cutting G . Guidelines for diagnosis of cystic fibrosis in newborns through older adults: Cystic Fibrosis Foundation consensus report. J Pediatr. 2008; 153(2):S4-S14. PMC: 2810958. DOI: 10.1016/j.jpeds.2008.05.005. View

11.

Herr C, Greulich T, Koczulla R, Meyer S, Zakharkina T, Branscheidt M . The role of vitamin D in pulmonary disease: COPD, asthma, infection, and cancer. Respir Res. 2011; 12:31. PMC: 3071319. DOI: 10.1186/1465-9921-12-31. View

12.

Oliveira M, Matsunaga N, Rodrigues M, Morcillo A, de Oliveira Ribeiro M, Ribeiro A . Lung disease and vitamin D levels in cystic fibrosis infants and preschoolers. Pediatr Pulmonol. 2019; 54(5):563-574. DOI: 10.1002/ppul.24260. View

13.

von Drygalski A, Biller J . Anemia in cystic fibrosis: incidence, mechanisms, and association with pulmonary function and vitamin deficiency. Nutr Clin Pract. 2008; 23(5):557-63. DOI: 10.1177/0884533608323426. View

14.

Henderson R, Lester G . Vitamin D levels in children with cystic fibrosis. South Med J. 1997; 90(4):378-83. DOI: 10.1097/00007611-199704000-00003. View

15.

Knight K, Wade S, Balducci L . Prevalence and outcomes of anemia in cancer: a systematic review of the literature. Am J Med. 2004; 116 Suppl 7A:11S-26S. DOI: 10.1016/j.amjmed.2003.12.008. View

16.

Wilson A, Yu H, Goodnough L, Nissenson A . Prevalence and outcomes of anemia in rheumatoid arthritis: a systematic review of the literature. Am J Med. 2004; 116 Suppl 7A:50S-57S. DOI: 10.1016/j.amjmed.2003.12.012. View

17.

Ongaratto R, Rosa K, Eloi J, Epifanio M, Marostica P, Pinto L . Association between hypovitaminosis D and frequency of pulmonary exacerbations in children and adolescents with cystic fibrosis. Einstein (Sao Paulo). 2018; 16(1):eAO4143. PMC: 6063747. DOI: 10.1590/s1679-45082018ao4143. View

18.

Hall W, Sparks A, Aris R . Vitamin d deficiency in cystic fibrosis. Int J Endocrinol. 2010; 2010:218691. PMC: 2817861. DOI: 10.1155/2010/218691. View

19.

Fridge J, Conrad C, Gerson L, Castillo R, Cox K . Risk factors for small bowel bacterial overgrowth in cystic fibrosis. J Pediatr Gastroenterol Nutr. 2007; 44(2):212-8. DOI: 10.1097/MPG.0b013e31802c0ceb. View

20.

Cooperman E, Park M, McKee J, Assad J . A simplified cystic fibrosis scoring system (a preliminary report). Can Med Assoc J. 1971; 105(6):580-2. PMC: 1931190. View